Smital Shah brings a trifecta of chemical engineering, consulting, and finance experience earned at heavyweight companies JP Morgan, Leerink, and Gilead to her role at clinical-stage RNA therapy biotech ProQR Therapeutics. We sat down for a deep conversation on the recipe for successful business and finance operations in an emerging biopharma organization.
|